$EVER

EverQuote at Oppenheimer conference: growth, ai and cash flow

EverQuote (EVER) told investors at the Oppenheimer conference that it has generated nearly $200 million in free cash flow over the past two years. The company reported 25% YoY Q2 revenue growth and 37% YoY EBITDA growth, and reiterated a path to $1 billion revenue in 15 to 27 months from its Nov 2025 target, driven by organic growth and AI-enabled Smart Campaigns.

Original reporting
Published Aug 13, 2026, 6:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 10:53 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$EVER
Bullish
medium confidence
Mentioned
$EVER · $OPY
Relevance
6/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$EVERBullishMed
01

Why it matters

The key trading takeaway is management’s reiterated $1B revenue path (15 to 27 months from the November 2025 target announcement) alongside quantified operating metrics and Smart Campaigns traction, which can influence near-term valuation expectations and positioning.

02

Market read

Traders may reprice EVER’s growth durability and cash-generation credibility based on the reiterated revenue timeline and Smart Campaigns momentum, while monitoring the acknowledged carrier spending caution.

03

What to watch

Smart Campaigns adoption is highlighted, but the article does not quantify customer concentration, retention, or how much of the growth is durable versus budget-cycle timing, which matters for forward estimates.

Relevance 6/10Novelty 6/10Timing: during/after the Oppenheimer conference on 2026-08-13

Background

EverQuote used the Oppenheimer 29th Annual Technology, Internet & Communications Conference to reiterate growth, cash flow, and AI strategy for its property and casualty insurance marketplace.

Company-level read

Ticker impact

$EVERBullishMedium confidence
Context

EverQuote told investors at Oppenheimer it generated nearly $200M free cash flow over two years and reiterated a path to $1B revenue within 15 to 27 months.

Expected impact

Near-term sentiment may stay supported if traders view the $1B revenue timeline and Smart Campaigns traction as credible, but upside may be capped by the acknowledged risk of overestimating AI disruption.

Evidence & confidence

The article provides specific, company-attributed metrics (FCF, revenue/EBITDA growth, Smart Campaigns adoption, and a $1B revenue timeline) but is not a fresh earnings print or filing, so the tradable catalyst is more sentiment and positioning than a new hard disclosure.

Market effects

Reinforces the insurance digital marketing and insurtech narrative that AI can improve lead conversion and efficiency without disrupting pricing dynamics.

No clear regional transmission beyond US small/mid-cap sentiment.

Limited, as the disclosures are company-specific and US-focused insurance marketplace operations.

Counterpoint

The company’s own caution about carriers’ more strategic spending and the risk of investors overestimating AI disruption could lead to multiple compression if growth expectations are too optimistic.

Key entities

  • EverQuote

    Insurance marketplace focused on property and casualty lead generation and carrier/agent performance via proprietary data and AI-enabled marketing tools.

  • Joseph Sanborn

    EverQuote CFO delivering the conference financial and operational updates.

Related articles

$OPYHigh

Why is Oppenheimer Holdings stock gaining over 2% today?

Oppenheimer Holdings stock rose 2.7% in pre-market trading to $123.25, surpassing its 52-week high, as the company distributed a $0.20 per share dividend. This follows strong Q2 2026 earnings, with revenue up 21.9% YoY to $454.9M and adjusted EPS at $4.27. Client assets under management reached a record $59.4B. The stock's technical breakout and positive fundamentals drove the gain, independent of broader market trends.

$ISRGMed

Oppenheimer Just Upgraded Intuitive Surgical Stock. Here's Why.

Oppenheimer upgraded Intuitive Surgical (ISRG) from “Perform” to “Outperform” and set a $500 price target, implying about 24.6% upside, citing robotic surgery growth and AI plans. The article notes Q2 revenue of $2.89B (vs $2.82B expected), EPS $2.80, da Vinci and Ion procedure growth, and ISRG guidance for da Vinci growth of 13.5% to 15.5%.

$EVERMedAI 8/10

Why EverQuote (EVER) Stock Is Up Today

EverQuote (NASDAQ:EVER) shares rose about 9% after the insurance marketplace reported Q2 results and guidance. Revenue increased 25% to $195.1 million, adjusted EBITDA rose 37% to a record $30.1 million, and management projected Q3 revenue of $198–$208 million and adjusted EBITDA of $28–$31 million. The stock closed at $25.71, up 7.9%.

$EVERMedAI 8/10

Why EverQuote (EVER) Stock Is Up Today

EverQuote (NASDAQ: EVER) shares rose about 9.4% intraday after the insurance marketplace reported Q2 revenue up 25% to $195.1 million and record adjusted EBITDA up 37% to $30.1 million. Auto revenue rose ~23% and home/renters ~35%. Q3 guidance calls for revenue $198–$208 million and adjusted EBITDA $28–$31 million.